Rheumatic Disease Clinics of North America

Papers
(The median citation count of Rheumatic Disease Clinics of North America is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Contributors76
Copyright51
Forthcoming Issues44
Contents37
Pediatric Rheumatology Comes of Age: Part II33
The Microbiome in Rheumatologic Diseases30
Treatment Guidelines in Rheumatoid Arthritis24
Outcome Measures in Pediatric Rheumatic Disease22
Contributors21
The Power of Systems Biology19
The Temporomandibular Joint in Juvenile Idiopathic Arthritis19
Contributors17
Copyright17
Precision Medicine17
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis17
Copyright16
Contents16
Copyright16
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases15
Fibromyalgia13
Copyright13
Nonpharmacologic Pain Management in Inflammatory Arthritis13
Time Trends of Cardiovascular Disease in the General Population and Inflammatory Arthritis13
Contents13
Implementation Science in Pediatric Rheumatology: A Path to Health Equity12
Contributors11
Recent Advances in Pediatric Vasculitis11
Contents11
Best Approaches to the Care of Systemic Sclerosis Patients11
Contributors10
Hal Holman of Stanford10
H. Ralph Schumacher10
Copyright10
Contents9
J. Claude Bennett, MD9
Gastrointestinal Tract Considerations Part I8
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus8
Contributors8
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis8
Beyond Coronary Artery Disease8
Vasculitis and Pregnancy8
Targeting Environmental Risks to Prevent Rheumatic Disease8
Recommendations for Systemic Lupus Erythematosus8
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy8
Systemic Lupus Erythematosus Risk7
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis7
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis7
Deficiency of Adenosine Deaminase 27
Osteoarthritis Treatment Guidelines from Six Professional Societies6
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis6
Rheumatoid Arthritis6
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis6
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children6
Forthcoming Issues5
Role of Environment in Pediatric Rheumatic Diseases5
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases5
Contents5
Copyright5
Management of Pregnancy in Lupus5
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy5
Contents5
COPA Syndrome from Diagnosis to Treatment5
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota5
Environmental Triggers of Hyperuricemia and Gout5
Systemic Lupus Erythematosus: The Next Generation of Ideas and Scientists5
Copyright5
Forthcoming Issues5
Contributors4
Copyright4
Foreword4
Statin-Associated Myalgias and Muscle Injury—Recognizing and Managing Both While Still Lowering the Low-Density Lipoprotein4
Forthcoming Issues4
SARS-CoV-2 Infection and COVID-19 in Children4
Approach to Systemic Sclerosis Patient Assessment4
Contents4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases4
Imaging of Rheumatic Diseases Affecting the Lower Limb3
Copyright3
Contributors3
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury3
Behçet Syndrome3
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”3
Eric Bywaters and Barbara Ansell3
Environmental Risks for Systemic Sclerosis3
The Role of Psychology in Pediatric Rheumatic Diseases3
Copyright3
Approach to Diagnosing Inborn Errors of Immunity3
Using the Electronic Health Record to Enhance Care in Pediatric Rheumatology3
Isolated Aortitis3
Treatment Guidelines in Pediatric Rheumatic Diseases3
Nathan Zvaifler3
Cardiovascular Health in Pediatric Rheumatologic Diseases3
Systemic Diseases and Heart Block3
Genetic Defects in Early-Onset Inflammatory Bowel Disease3
Patient Engagement in Pediatric Rheumatology Research3
Environmental Triggers for Rheumatic Diseases3
Gerald P Rodnan3
Preface3
The Promises and Perils of Social Media for Pediatric Rheumatology2
Treatment Guidelines in Gout2
Why It Hurts2
Basic Mechanisms of Pain in Osteoarthritis2
Pediatric Rheumatic Disease in Lower to Middle-Income Countries2
Immune Checkpoint Inhibitor-induced Sicca Syndrome2
Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes2
CARRA2
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma2
Unique Aspects of Pediatric Sjögren Disease2
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica2
Cannabinoids and Pain2
Rheumatic Immune-related Adverse Events2
Management and Cure of Gouty Arthritis2
Neutrophil Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus2
Patient Voices in Rheumatic Immune-related Adverse Events2
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk2
Rheumatic Disease Clinics of North America2
Pediatric Rheumatology Comes of Age: Part I2
T Cells in Systemic Lupus Erythematosus2
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases1
Pain in Rheumatic Diseases1
Juvenile Fibromyalgia1
Contents1
Imaging Challenges and Developments in Large-vessel Vasculitis1
Venous Thromboembolism in the Inflammatory Rheumatic Diseases1
Recent Updates in Juvenile Spondyloarthritis1
The Giants Of Rheumatology1
Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression1
Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy1
Coronavirus Disease-2019 in the Immunocompromised Host1
John R. Ward, MD: Pioneer—Clinical Trials in Rheumatology1
Contributors1
Imaging in Rheumatology1
Imaging in Inflammatory Bowel Disease1
Environmental Triggers for Vasculitis1
Interventions to Improve COVID-19 Vaccine Hesitancy1
Edmund Lawrence Dubois (1923–1985)1
Highlights of Interdisciplinary Care in Rheumatology1
Pediatric Rheumatology Comes of Age: Part I1
Copyright1
Pain in Rheumatic Diseases1
Forthcoming Issues1
Lessons Learned from the COVID-19 Pandemic in Rheumatology1
Taxonomy of Quality of Care Indicators1
Health Care Utilization1
Contributors1
How the American College of Rheumatology Develops Guidelines0
Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus0
Rheumatology Pearls for the Primary Care Physician0
Preventative Care in Scleroderma0
Sexual Dimorphism in the Expression of Pain Phenotype in Preclinical Models of Rheumatoid Arthritis0
Environmental Risks for Spondyloarthropathies0
Foreword0
Imaging of the Major Salivary Glands in Rheumatic Disease0
E Carwile LeRoy, MD0
Cardiovascular Complications of Chronic Rheumatic Diseases0
Contributors0
Patient-Reported Outcomes in Lupus0
Lessons on Telemedicine in Rheumatology0
Rheumatic Complications of Immune Checkpoint Inhibitors0
The Future of Vasculitis0
Contributors0
Forthcoming Issues0
Type I Interferonopathies0
Lessons from Carl M. Pearson 1919 – 19810
Pediatric Rheumatology Comes of Age: Part I0
Juvenile Localized Scleroderma0
Suppressor of Cytokine Signaling 1 Haploinsufficiency0
Immune Checkpoint Inhibitor-induced Myositis0
Charles L Christian0
Early Sexual Health and Reproductive Implications in Pediatric Rheumatic Diseases0
Forthcoming Issues0
Contents0
Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials0
De novo Connective Tissue Disorders as Immune-related Adverse Events0
Heart Failure in Rheumatic Disease0
New Developments in Imaging in Crystalline Arthritis0
Pain in Axial Spondyloarthritis0
Environmental Triggers for Rheumatic Diseases0
Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination0
Highlights of Interdisciplinary Care in Rheumatology0
Gastrointestinal Tract Considerations: Part II0
It Takes Oysters to Generate Pearls0
Transitioning to Adulthood with a Rheumatic Disease0
Mental Health Considerations in Chronic Disease0
Pulmonary Hypertension0
Management of Knee Osteoarthritis0
Animal Models Informing the Role of the Microbiome and its Metabolites in Rheumatoid Arthritis0
Contents0
Forthcoming Issues0
Guideline Development and Implementation in Rheumatic Disease0
Contributors0
Environmental Risks for Inflammatory Myopathies0
COVID-19 and Rheumatology0
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis0
Contents0
Scleroderma: Best Approaches to Patient Care0
Systemic Autoinflammatory Diseases0
The Exciting Future for Scleroderma0
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease0
Imaging of Pulmonary Manifestations of Connective Tissue Disease0
Upper Respiratory Microbiome in Vasculitis0
Preventative Care in Scleroderma0
Foreword0
Naomi Rothfield, MD, MACR0
Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis0
Connective Tissue Disease Associated Interstitial Lung Disease0
Forthcoming Issues0
Systemic Lupus Erythematosus Classification and Diagnosis0
Treatment Update in Systemic Lupus Erythematous0
Copyright0
The Role of Pediatric Rheumatologists in Autoimmune Brain Disease0
Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases0
Forthcoming Issues0
Targeted Treatment of Diseases of Immune Dysregulation0
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis0
Forthcoming Issues0
Imaging in Juvenile Idiopathic Arthritis0
Copyright0
Epidemiologic Opportunities and Challenges in Studying Environmental Risk Factors for Rheumatic Diseases0
Perioperative Management of Rheumatic Disease and Therapies0
Contents0
Imaging Modalities in Myositis0
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 20190
Emerging Concepts in Immune Dysregulation0
Walter Bauer, Marian Wilkins Ropes, and the Massachusetts General Hospital0
Pain in Rheumatic Diseases0
The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis0
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus0
Long COVID for the Rheumatologist0
The Evaluation of Guideline Quality in Rheumatic Diseases0
Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders0
Vasculitis Mimics and Other Related Conditions0
Guideline Development and Implementation in Rheumatic Disease0
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD0
COVID-19 in Pediatrics0
Pediatric Rheumatology Comes of Age: Part II0
Lupus0
Central Nervous System Vasculitis0
Imaging in Rheumatic Immune-related Adverse Events0
Cardiac MRI in Rheumatic Disease0
Lupus Cohorts0
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events0
A Guide to Contemporary Clinical Practice Guidelines0
Daniel J McCarty, MD: A Giant of Rheumatology0
Treatment of Inflammatory Arthritis in Systemic Sclerosis0
Contents0
Training the Next Generation of Rheumatologists0
Copyright0
Axial Imaging in Spondyloarthritis0
New and Emerging Rheumatic Diseases0
0.17907094955444